T cell-mediated immune deficiency or compromise in patients with CTEPH

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 3, 2011, Pages 417-418

  Song, Haoming ^a   Wang, Lemin ^a   Gong, Zhu ^a   Liang, Aibin ^a   Xie, Yuan ^a   Lv, Wei ^a   Jiang, Jinfa ^a   Xu, Wenjun ^a   Shen, Yuqin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE DEFICIENCY; LETTER; LUNG EMBOLISM; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; T LYMPHOCYTE;

EID: 79551517288     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.183.3.417     Document Type: Letter

References (6)

1. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the medenox study. Arch Intern Med 2004;164: 963-968.
2. Gong Z, Liang AB, Wang LM, Zhang XY, Wang Q, Huang CY, Song HM, Wang H, Shen YQ, Gao HJ, et al. The expression and significance of immunity associated genes mrna in patients with pulmonary embolism [in Chinese]. Zhonghua Nei Ke Za Zhi 2009; 48:666-669.
3. Wang L, Gong Z, Liang A, Xie Y, Liu SL, Yu Z, Wang Y. Compromised T-cell immunity and virus-like structure in a patient with pulmonary hypertension. Am J Respir Crit Care Med 2010;182:434-435.
4. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264.
5. Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 2009;53:1211-1218.
6. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006;367:1075-1079.